IQT (In-Q-Tel) is a not-for-profit global investment firm established in 1999 by the CIA. Its primary mission is to accelerate the transition of groundbreaking technologies from the private sector to the public sector, with a focus on enhancing the national security and economic prosperity of the United States and its allies. IQT operates as a strategic investment platform that identifies, evaluates, and leverages innovative startups and their technologies across a wide range of frontier tech domains. This includes biotechnology, microchips, AI, and space systems. IQT's investment strategy revolves around identifying startups with game-changing innovations in strategic technology areas. They evaluate how these innovations can best serve the current and future mission needs of their government partners. A core aspect of their approach involves adapting and transferring cutting-edge technologies to maximize their impact for government use while also enhancing the companies' commercial success. This dual-purpose strategy ensures that portfolio companies benefit from government adoption while also expanding their market opportunities. IQT has cultivated enduring strategic relationships with over a dozen U.S. government partners, as well as with the United Kingdom and Australia. The firm shares its global insights into the venture capital-backed technology ecosystem with these partners, constantly evolving its operations to stay at the forefront of tech-driven innovation. They also offer a Government Platform Accelerator program to assist startups in navigating and successfully entering the government market. IQT's approach involves a deep understanding of both the technology landscape and the needs of the national security community. They leverage their in-house expertise to bridge the gap between the two, ensuring that critical innovations reach the public sector and contribute to national security and economic prosperity. Their milestone history demonstrates a commitment to expanding their reach and impact through strategic investments and partnerships.
Preferred startup development maturity for initial funding deployment.
Biotechnology, Microchips, AI, Space Systems, Microelectronics & Quantum, Energy, Cyber, Life Sciences, Hardware
Core thematic spaces, technologies, and target market segments of interest.
Standard financial allocation per investment round.
Direct Verification Contact Email Pattern
Thesis Dossier Analysis Scorecard
Our agent analyzer scanned portfolio holdings and verified absolute match parameters...